☰

Ching L. Lin, Ph.D. - Publications

Affiliations: 
2008 The Claremont Graduate University 
Area:
General
Tree Info Similar researchers PubMed Report error

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lin CL, Tseng KC, Chen KY, Liao LY, Kao JH. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32653388 DOI: 10.1016/j.jfma.2020.07.003  0.459
2020 Lin CL, Kao JH. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence. Gastroenterology Clinics of North America. 49: 201-214. PMID 32389359 DOI: 10.1016/j.gtc.2020.01.010  0.517
2019 Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, et al. Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East-Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of Gastroenterology and Hepatology. PMID 30931537 DOI: 10.1111/jgh.14672  0.538
2018 Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30448077 DOI: 10.1016/j.jfma.2018.10.020  0.49
2018 Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan. Alimentary Pharmacology & Therapeutics. PMID 30362139 DOI: 10.1111/apt.15011  0.395
2018 Lin CL. Combination therapy for chronic hepatitis B: The future and beyond. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29705222 DOI: 10.1016/j.jfma.2018.04.006  0.387
2018 Lin CL, Kao JH. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination. Hepatology International. PMID 29619622 DOI: 10.1007/s12072-018-9863-0  0.494
2017 Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Practice & Research. Clinical Gastroenterology. 31: 249-255. PMID 28774406 DOI: 10.1016/j.bpg.2017.04.010  0.559
2017 Yu MW, Lin CL, Liu CJ, Yang SH, Tseng YL, Wu CF. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study. Gastroenterology. PMID 28711626 DOI: 10.1053/j.gastro.2017.07.001  0.342
2017 Lin CL, Kao JH. Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace. Hepatology International. PMID 28058576 DOI: 10.1007/s12072-016-9782-x  0.523
2016 Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology. 22: 423-431. PMID 28081591 DOI: 10.3350/cmh.2016.0069  0.556
2016 Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, et al. Four-Year Entecavir Therapy Reduces Hepatocellular Carcinoma, Cirrhotic Events, and Mortality in Chronic Hepatitis B Patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27634134 DOI: 10.1111/liv.13253  0.495
2016 Sung FY, Lan CY, Huang CJ, Lin CL, Liu CJ, Chen PJ, Lin SM, Yu MW. Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 27228506 DOI: 10.1002/hep.28654  0.335
2016 Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 85-92. PMID 26725903 DOI: 10.1111/Liv.13003  0.392
2015 Tseng KC, Tseng CW, Hsieh TY, Peng CY, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Efficacy of entecavir therapy for HBeAg-positive chronic hepatitis B patients with prior exposure to interferon or nucleos(t)ide analogues. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 26422680 DOI: 10.1111/hepr.12600  0.36
2015 Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. Hepatology International. PMID 26399763 DOI: 10.1007/s12072-015-9662-9  0.521
2015 Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26279173 DOI: 10.1016/j.jfma.2015.07.004  0.513
2015 Lin CL, Kao JH. Perspectives and control of hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 114: 901-9. PMID 26184565 DOI: 10.1016/j.jfma.2015.06.003  0.387
2015 Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harbor Perspectives in Medicine. 5: a021436. PMID 25934462 DOI: 10.1101/cshperspect.a021436  0.414
2015 Lin CL, Kao JH. Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Hepatology (Baltimore, Md.). PMID 25914237 DOI: 10.1002/hep.27865  0.528
2015 Liu CH, Liang CC, Liu CJ, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Kao JH. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. Journal of Clinical Microbiology. 53: 1754-7. PMID 25740780 DOI: 10.1128/Jcm.03548-14  0.461
2015 Lin CL, Tseng TC, Kao JH. What can we learn from hepatitis B virus clinical cohorts? Liver International : Official Journal of the International Association For the Study of the Liver. 35: 91-9. PMID 25529093 DOI: 10.1111/liv.12716  0.416
2015 Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 114: 308-13. PMID 24315616 DOI: 10.1016/j.jfma.2013.10.023  0.542
2014 Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. Journal of Clinical Gastroenterology. PMID 25319739 DOI: 10.1097/MCG.0000000000000250  0.423
2014 Su W, Hsieh T, Hsieh T, Tseng K, Peng C, Lin C, Su T, Hsiao T, Tseng T, Lin HH, Wang C, Kao J. Younger age and female sex predict a better therapeutic response in HBeAg-positive chronic hepatitis B patients to entecavir therapy Advances in Digestive Medicine. 1: 112-117. DOI: 10.1016/J.AIDM.2014.03.003  0.325
2013 Huang CJ, Wu CF, Lan CY, Sung FY, Lin CL, Liu CJ, Liu HF, Yu MW. Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression. Plos One. 8: e70169. PMID 23936156 DOI: 10.1371/journal.pone.0070169  0.368
2013 Lin CL, Kao JH. Hepatitis B viral factors and treatment responses in chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 112: 302-11. PMID 23787007 DOI: 10.1016/j.jfma.2013.02.001  0.402
2013 Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, et al. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (Baltimore, Md.). 57: 2135-42. PMID 23322699 DOI: 10.1002/Hep.26266  0.386
2013 Lin CL, Kao JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 28: 10-7. PMID 23094699 DOI: 10.1111/jgh.12010  0.37
2013 Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir. Journal of Gastroenterology and Hepatology. 28: 46-50. PMID 22989322 DOI: 10.1111/j.1440-1746.2012.07269.x  0.415
2013 Lin CL, Kao JH. Hepatitis B virus genotypes: Clinical relevance and therapeutic implications Current Hepatitis Reports. 12: 124-132. DOI: 10.1007/s11901-013-0166-6  0.422
2012 Lin CL, Tseng TC, Su TH, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission. Hepatology International. 6: 598-605. PMID 21779934 DOI: 10.1007/s12072-011-9297-4  0.408
2011 Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy. Antiviral Therapy. 16: 629-37. PMID 21817184 DOI: 10.3851/IMP1841  0.383
2011 Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opinion On Pharmacotherapy. 12: 2025-40. PMID 21682661 DOI: 10.1517/14656566.2011.590474  0.357
2011 Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances. Journal of Gastroenterology and Hepatology. 26: 123-30. PMID 21199523 DOI: 10.1111/j.1440-1746.2010.06541.x  0.418
2011 Huang HH, Shih WL, Li YH, Wu CF, Chen PJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Lee SD, Yu MW. Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway. Gut. 60: 99-107. PMID 20980339 DOI: 10.1136/gut.2010.207670  0.346
2010 Lin CL, Kao JH. Clinical implications of hepatitis B virus variants Journal of the Formosan Medical Association. 109: 321-325. PMID 20514738 DOI: 10.1016/S0929-6646(10)60059-9  0.377
2009 Sung FY, Jung CM, Wu CF, Lin CL, Liu CJ, Liaw YF, Tsai KS, Yu MW. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression. Gastroenterology. 137: 1687-97. PMID 19664630 DOI: 10.1053/j.gastro.2009.07.063  0.36
2008 Tsai CY, Lin CL, Lin SC, Liou SW. Detection of hepatitis B virus in the aqueous humor of a hepatitis B virus carrier. Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde. 223: 93-5. PMID 19023227 DOI: 10.1159/000175640  0.408
2008 Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH. Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1260-9. PMID 18834319 DOI: 10.1086/592579  0.315
2008 Lin CL, Branch RA, Kao JH. Combination of Hepatitis B Viral Factors and Advanced Liver Disease in HBeAg-Negative Patients: The More, the Worse? Gastroenterology. 134: 1270-1271. PMID 18395114 DOI: 10.1053/j.gastro.2007.12.045  0.545
2008 Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B Journal of Biomedical Science. 15: 137-145. PMID 18058038 DOI: 10.1007/s11373-007-9225-8  0.449
2007 Lin CL, Kao JH. Viremia Profiles in Hepatitis B Virus Carrier Children With Spontaneous e Antigen Seroconversion: A Case of Déjà Vu? Gastroenterology. 133: 1052-1053. PMID 17854613 DOI: 10.1053/j.gastro.2007.07.015  0.473
2007 Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, Chen DS. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. 27: 983-8. PMID 17696938 DOI: 10.1111/j.1478-3231.2007.01546.x  0.447
2007 Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 22: 1098-103. PMID 17608857 DOI: 10.1111/j.1440-1746.2006.04515.x  0.351
2007 Lin C, Kao JH. To genotype or not to genotype: Toward an optimal tailoring of treatment of chronic hepatitis B [3] Clinical Infectious Diseases. 44: 1665-1666. PMID 17516416 DOI: 10.1086/518386  0.351
2007 Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ, Lai MY, Chen DS, Kao JH. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology (Baltimore, Md.). 45: 1193-8. PMID 17464993 DOI: 10.1002/hep.21585  0.313
2007 Lin CL, Kao JH. Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma Future Virology. 2: 441-443. DOI: 10.2217/17460794.2.5.441  0.391
2007 Lin CL, Kao JH. Intrafamilial transmission of hepatitis B virus infection [3] Journal of Gastroenterology and Hepatology (Australia). 22: 765-766. DOI: 10.1111/j.1440-1746.2007.04825.x  0.355
2006 Lin TJ, Liao LY, Lin SY, Lin CL, Chang TA. Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C. World Journal of Gastroenterology. 12: 4897-901. PMID 16937477 DOI: 10.3748/wjg.v12.i30.4897  0.348
2006 Huang YW, Lin CL, Chen PJ, Lai MY, Kao JH, Chen DS. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. Journal of Gastroenterology and Hepatology. 21: 859-62. PMID 16704536 DOI: 10.1111/j.1440-1746.2006.04280.x  0.355
2006 Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study. Hepatology (Baltimore, Md.). 43: 742-9. PMID 16557544 DOI: 10.1002/hep.21100  0.386
2005 Lin CL, Kao JH, Chen BF, Chen PJ, Lai MY, Chen DS. Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1576-81. PMID 16267729 DOI: 10.1086/497837  0.356
2005 Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. International Journal of Epidemiology. 34: 1310-8. PMID 16172101 DOI: 10.1093/ije/dyi191  0.324
2005 Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 564-70. PMID 15910494 DOI: 10.1111/j.1478-3231.2005.01041.x  0.466
2005 Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. Journal of the National Cancer Institute. 97: 265-72. PMID 15713961 DOI: 10.1093/jnci/dji043  0.382
2004 Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver International : Official Journal of the International Association For the Study of the Liver. 24: 9-15. PMID 15101995 DOI: 10.1111/j.1478-3231.2004.00893.x  0.457
2003 Yu MW, Chang HC, Chen PJ, Liu CJ, Liaw YF, Lin SM, Lee SD, Lin SC, Lin CL, Chen CJ. Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. International Journal of Epidemiology. 31: 1008-15. PMID 12435776 DOI: 10.1093/ije/31.5.1008  0.3
2002 Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. Journal of Gastroenterology. 37: 283-7. PMID 11993512 DOI: 10.1007/s005350200036  0.429
1973 Lin CL, Lee SC. Transient state analysis of separated flow around a sphere Computers and Fluids. 1: 235-250. DOI: 10.1016/0045-7930(73)90009-1  0.336
Show low-probability matches.